Industry News
The Efficacy Of A Targeted Therapy Against Virus-Induced Lymphomas Impeded By Viral Replication
Apr 05, 2012
Kaposi's sarcoma herpesvirus (KSHV) is a human tumor virus and an etiological agent for Kaposi's sarcoma and primary effusion lymphoma (PEL). PELs are aggressive lymphomas with reported median survival time shorter than six months after diagnosis... Read More
Key Mechanism Behind Lymphoma Targeted By New Compound
Apr 05, 2012
Scientists at Fox Chase Cancer Center in Philadelphia have come one step closer to developing the first treatment to target a key pathway in lymphoma. The new findings was announced at the AACR Annual Meeting 2012. "It's an exciting time to be involved in lymphoma treatment and research," says study author Mitchell Smith, M.D., Ph.D., director of Lymphoma Service at Fox Chase... Read More
Link Discovered Between Estrogen And Tobacco Smoke
Apr 05, 2012
The hormone estrogen may help promote lung cancer - including compounding the effects of tobacco smoke on the disease - pointing towards potential new therapies that target the hormone metabolism, according to new research presented at the AACR Annual Meeting 2012 by scientists at Fox Chase Cancer Center in Philadelphia... Read More
Health Problems Linger For Survivors Of Oesophageal Cancer Surgery
Apr 05, 2012
Oesophageal cancer is a very serious form of cancer that, if not fatal, requires extensive surgery. A new study from Karolinska Institutet shows that when serious complications arise after surgery for oesophageal cancer, many patients suffer other health problems, such as breathlessness, fatigue, insomnia and eating problems, for five years afterwards... Read More
Gene Sequencing Limited As Disease Predictor, Study
Apr 05, 2012
If current trends continue, the cost of having one's genome analyzed will be comparable to that of the weekly supermarket bill. But will this give us the ability to predict which common diseases are likely to afflict us in the future? Well, according to a new study of twins that was published this week in Science Translational Medicine, the answer in most cases is likely to be no... Read More
From Cancer Drug To Diabetes
Apr 05, 2012
The drug known as rapamycin is widely used by cancer and transplant patients, and there are hints that it might even help us put off old age and live longer. But, it also comes with a downside: rapamycin leads to diabetes in as many as 15 percent of the people who take it. Now, researchers reporting in the April Cell Metabolism, a Cell Press publication, have figured out why that is... Read More
Link Between Breast Cancer Resistance And Timing Of Soy Consumption
Apr 05, 2012
Studies exploring the relationship between soy consumption and breast cancer have been mixed, but new research introduces a new thought: Could women with breast cancer who began eating soy as an adult develop a tumor more resistant to treatment? That's the suggestion of a new study in animal models that could provide important hints for women with breast cancer who eat soy... Read More
Risk For Prostate Cancer Recurrence Increased By Excess Body Weight
Apr 05, 2012
Researchers have found an association between excess body weight and an increased risk for cancer recurrence in men with clinically localized prostate cancer. "Men diagnosed with early-stage prostate cancer and who have excess body weight as indicated by a higher-than-normal body mass index (BMI) have an increased risk for cancer recurrence after treatment," said Vincent L. Freeman, M.D., M.P... Read More
DNA Marker Discovered That May Predict Ovarian Cancer Treatment Success
Apr 05, 2012
Researchers and doctors at the North Shore-LIJ Health System and the Feinstein Institute for Medical Research have discovered that blood can help determine the best treatment plan for patients with ovarian cancer... Read More
In Ovarian Cancer, Increasing Height And Body Mass Index Found To Be Risk Factors
Apr 05, 2012
A study in this week's PLoS Medicine suggests that increasing height and, among women who have never taken menopausal hormone therapy, increased body mass index are risk factors for developing ovarian cancer. These findings are important as in high income countries, the average height and average body mass index of women have increased by about 1 cm and 1 kg/m2 respectively per decade... Read More
Previous Page Next Page